President Aleksandar Vucic of Serbia, battered by months of nationwide protests, is struggling to weather his biggest political crisis in more than a decade of rule. By Andrew Higgins Reporting ...

The Serbian Finance Ministry’s Administration for the Prevention of Money Laundering has asked banks to hand over data about the bank accounts and transactions of five activists, it was reported ...

Free of the burden of the 1990s, Serbia’s protesting students are focused on specific problems rather than final aims, and that’s why they might succeed where others failed, astrophysicist ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, getting a green light in China for sacituzumab tirumotecan (sac-TMT).

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...